Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Liver Cirrhosis | 41 | 2023 | 48 | 11.930 |
Why?
|
Liver Neoplasms | 26 | 2021 | 45 | 7.520 |
Why?
|
Hepatic Stellate Cells | 30 | 2023 | 30 | 6.570 |
Why?
|
Animals | 102 | 2023 | 1238 | 5.510 |
Why?
|
Signal Transduction | 38 | 2020 | 180 | 4.950 |
Why?
|
Liver | 34 | 2023 | 120 | 4.560 |
Why?
|
Hepatocytes | 34 | 2022 | 81 | 4.550 |
Why?
|
Carcinoma, Hepatocellular | 19 | 2021 | 32 | 4.490 |
Why?
|
Non-alcoholic Fatty Liver Disease | 12 | 2022 | 24 | 4.340 |
Why?
|
Mice | 73 | 2023 | 508 | 4.070 |
Why?
|
Fatty Liver | 16 | 2020 | 53 | 3.570 |
Why?
|
Liver Diseases, Alcoholic | 9 | 2022 | 24 | 3.250 |
Why?
|
Humans | 65 | 2023 | 2493 | 3.150 |
Why?
|
Transforming Growth Factor beta | 11 | 2022 | 81 | 2.750 |
Why?
|
Hyaluronic Acid | 5 | 2023 | 5 | 2.710 |
Why?
|
Toll-Like Receptor 4 | 13 | 2019 | 16 | 2.560 |
Why?
|
Ethanol | 8 | 2022 | 52 | 2.550 |
Why?
|
Mice, Inbred C57BL | 38 | 2022 | 185 | 2.490 |
Why?
|
Inflammation | 11 | 2022 | 44 | 2.370 |
Why?
|
Apoptosis | 12 | 2019 | 162 | 2.350 |
Why?
|
Toll-Like Receptor 9 | 4 | 2017 | 4 | 2.030 |
Why?
|
Toll-Like Receptor 2 | 7 | 2019 | 9 | 1.930 |
Why?
|
Male | 51 | 2021 | 1649 | 1.890 |
Why?
|
Kupffer Cells | 20 | 2020 | 20 | 1.890 |
Why?
|
MAP Kinase Kinase Kinases | 5 | 2019 | 6 | 1.800 |
Why?
|
Liver Neoplasms, Experimental | 7 | 2021 | 10 | 1.720 |
Why?
|
Mice, Knockout | 28 | 2021 | 112 | 1.680 |
Why?
|
Hyaluronan Synthases | 3 | 2022 | 3 | 1.650 |
Why?
|
Macrophages | 7 | 2019 | 22 | 1.610 |
Why?
|
Liver Diseases | 6 | 2016 | 14 | 1.580 |
Why?
|
MicroRNAs | 5 | 2022 | 41 | 1.560 |
Why?
|
Chemical and Drug Induced Liver Injury | 6 | 2019 | 12 | 1.450 |
Why?
|
Obesity | 5 | 2022 | 102 | 1.400 |
Why?
|
Membrane Glycoproteins | 8 | 2020 | 62 | 1.390 |
Why?
|
NF-kappa B | 9 | 2020 | 26 | 1.270 |
Why?
|
Lipid Metabolism | 6 | 2014 | 24 | 1.210 |
Why?
|
Autophagy | 5 | 2021 | 10 | 1.190 |
Why?
|
Toll-Like Receptors | 10 | 2018 | 15 | 1.170 |
Why?
|
Adaptor Proteins, Signal Transducing | 9 | 2016 | 11 | 1.150 |
Why?
|
Female | 27 | 2022 | 1733 | 1.150 |
Why?
|
Inflammasomes | 4 | 2019 | 9 | 1.140 |
Why?
|
Gene Expression Regulation | 9 | 2023 | 93 | 1.130 |
Why?
|
Extracellular Matrix | 3 | 2023 | 12 | 1.130 |
Why?
|
Cell Proliferation | 9 | 2019 | 110 | 1.080 |
Why?
|
Choline Deficiency | 5 | 2021 | 5 | 1.070 |
Why?
|
Cytokines | 8 | 2015 | 47 | 1.050 |
Why?
|
Receptors, Chemokine | 2 | 2018 | 4 | 1.040 |
Why?
|
Carcinogenesis | 5 | 2021 | 12 | 1.030 |
Why?
|
Insulin Resistance | 4 | 2021 | 44 | 1.000 |
Why?
|
Liver Regeneration | 8 | 2012 | 10 | 0.990 |
Why?
|
Hymecromone | 2 | 2021 | 2 | 0.980 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 2 | 2014 | 11 | 0.960 |
Why?
|
Disease Models, Animal | 15 | 2022 | 143 | 0.950 |
Why?
|
Endoplasmic Reticulum Stress | 2 | 2021 | 5 | 0.930 |
Why?
|
Toll-Like Receptor 7 | 2 | 2020 | 2 | 0.930 |
Why?
|
Gastrointestinal Tract | 2 | 2014 | 3 | 0.920 |
Why?
|
Serine Endopeptidases | 1 | 2023 | 10 | 0.920 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2021 | 4 | 0.920 |
Why?
|
Lipopolysaccharides | 13 | 2019 | 20 | 0.910 |
Why?
|
A Kinase Anchor Proteins | 1 | 2022 | 1 | 0.910 |
Why?
|
Mitochondria, Liver | 2 | 2019 | 5 | 0.890 |
Why?
|
Intestinal Mucosa | 2 | 2020 | 8 | 0.880 |
Why?
|
Liver Cirrhosis, Experimental | 4 | 2010 | 4 | 0.870 |
Why?
|
Interleukin-1beta | 5 | 2019 | 5 | 0.840 |
Why?
|
Mice, Transgenic | 14 | 2021 | 37 | 0.820 |
Why?
|
Cells, Cultured | 17 | 2018 | 164 | 0.800 |
Why?
|
Interleukins | 1 | 2020 | 3 | 0.800 |
Why?
|
Receptors, CCR2 | 2 | 2012 | 6 | 0.790 |
Why?
|
Up-Regulation | 10 | 2019 | 71 | 0.790 |
Why?
|
Down-Regulation | 2 | 2018 | 52 | 0.780 |
Why?
|
Endothelial Cells | 1 | 2020 | 7 | 0.770 |
Why?
|
Interferon Regulatory Factor-1 | 2 | 2019 | 2 | 0.760 |
Why?
|
Gene Expression Regulation, Neoplastic | 8 | 2020 | 77 | 0.730 |
Why?
|
MafG Transcription Factor | 2 | 2018 | 2 | 0.730 |
Why?
|
Proteolysis | 1 | 2019 | 1 | 0.720 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2019 | 12 | 0.720 |
Why?
|
Calcium-Binding Proteins | 1 | 2019 | 2 | 0.720 |
Why?
|
Colonic Neoplasms | 1 | 2019 | 4 | 0.720 |
Why?
|
Gene Deletion | 4 | 2013 | 7 | 0.700 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2021 | 17 | 0.690 |
Why?
|
Fibrosis | 4 | 2023 | 63 | 0.690 |
Why?
|
NF-kappa B p50 Subunit | 3 | 2018 | 4 | 0.680 |
Why?
|
Chemokines | 2 | 2018 | 2 | 0.670 |
Why?
|
Neutrophil Infiltration | 2 | 2015 | 2 | 0.660 |
Why?
|
Membrane Proteins | 2 | 2018 | 15 | 0.660 |
Why?
|
Myofibroblasts | 2 | 2015 | 3 | 0.640 |
Why?
|
Cellular Senescence | 2 | 2015 | 6 | 0.630 |
Why?
|
Pyridines | 2 | 2020 | 22 | 0.610 |
Why?
|
MAP Kinase Signaling System | 2 | 2014 | 7 | 0.600 |
Why?
|
Diet, High-Fat | 3 | 2016 | 54 | 0.590 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2016 | 1 | 0.580 |
Why?
|
Myeloid Differentiation Factor 88 | 8 | 2015 | 10 | 0.580 |
Why?
|
Fatty Acids | 2 | 2014 | 13 | 0.580 |
Why?
|
Macrophage Migration-Inhibitory Factors | 1 | 2016 | 1 | 0.570 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2016 | 1 | 0.570 |
Why?
|
Pancreatic Neoplasms | 1 | 2016 | 4 | 0.570 |
Why?
|
Hedgehog Proteins | 1 | 2016 | 1 | 0.570 |
Why?
|
Anilides | 1 | 2016 | 5 | 0.570 |
Why?
|
Tumor Necrosis Factor-alpha | 8 | 2019 | 26 | 0.570 |
Why?
|
Exosomes | 1 | 2016 | 6 | 0.570 |
Why?
|
Bile Acids and Salts | 1 | 2015 | 2 | 0.560 |
Why?
|
Chemokine CXCL1 | 1 | 2015 | 3 | 0.540 |
Why?
|
Receptors, Immunologic | 4 | 2005 | 7 | 0.540 |
Why?
|
Antigens, Differentiation | 4 | 2005 | 6 | 0.540 |
Why?
|
Hepatitis | 1 | 2015 | 2 | 0.530 |
Why?
|
Polysaccharides | 1 | 2014 | 2 | 0.530 |
Why?
|
RNA, Messenger | 9 | 2022 | 167 | 0.520 |
Why?
|
Deoxycholic Acid | 1 | 2014 | 1 | 0.500 |
Why?
|
Biomarkers | 6 | 2023 | 58 | 0.480 |
Why?
|
Methionine Adenosyltransferase | 3 | 2022 | 4 | 0.470 |
Why?
|
Cholestasis | 5 | 2018 | 7 | 0.470 |
Why?
|
DNA, Neoplasm | 1 | 2013 | 7 | 0.460 |
Why?
|
Palmitic Acid | 1 | 2013 | 3 | 0.460 |
Why?
|
Carbon Tetrachloride Poisoning | 4 | 2010 | 4 | 0.460 |
Why?
|
TOR Serine-Threonine Kinases | 5 | 2019 | 11 | 0.440 |
Why?
|
Monocytes | 1 | 2012 | 13 | 0.440 |
Why?
|
Receptors, Cell Surface | 4 | 2005 | 18 | 0.430 |
Why?
|
Disease Progression | 5 | 2023 | 50 | 0.420 |
Why?
|
Cholangiocarcinoma | 3 | 2021 | 3 | 0.420 |
Why?
|
Tumor Microenvironment | 3 | 2021 | 6 | 0.420 |
Why?
|
Collagen Type I | 6 | 2021 | 15 | 0.420 |
Why?
|
Cancer-Associated Fibroblasts | 2 | 2021 | 2 | 0.410 |
Why?
|
Bone Marrow | 1 | 2011 | 2 | 0.410 |
Why?
|
Fatty Liver, Alcoholic | 1 | 2011 | 2 | 0.410 |
Why?
|
Glial Cell Line-Derived Neurotrophic Factor | 2 | 2022 | 4 | 0.400 |
Why?
|
Chemokine CX3CL1 | 1 | 2010 | 1 | 0.390 |
Why?
|
Mitochondria | 3 | 2022 | 26 | 0.390 |
Why?
|
Cell Line, Tumor | 7 | 2021 | 138 | 0.390 |
Why?
|
Reactive Oxygen Species | 8 | 2016 | 36 | 0.390 |
Why?
|
Mitochondrial Proteins | 2 | 2022 | 8 | 0.390 |
Why?
|
Carbon Tetrachloride | 7 | 2022 | 7 | 0.380 |
Why?
|
Mice, Inbred BALB C | 12 | 2018 | 30 | 0.370 |
Why?
|
Proto-Oncogene Proteins c-met | 2 | 2021 | 2 | 0.370 |
Why?
|
Bile Duct Neoplasms | 2 | 2021 | 2 | 0.370 |
Why?
|
Phosphorylation | 5 | 2022 | 68 | 0.370 |
Why?
|
STAT3 Transcription Factor | 3 | 2014 | 21 | 0.370 |
Why?
|
Tumor Suppressor Proteins | 2 | 2020 | 5 | 0.370 |
Why?
|
Receptors, CCR5 | 1 | 2009 | 1 | 0.360 |
Why?
|
Receptors, CCR1 | 1 | 2009 | 1 | 0.360 |
Why?
|
Interleukin-18 | 5 | 2004 | 6 | 0.350 |
Why?
|
Hyaluronan Receptors | 2 | 2019 | 8 | 0.350 |
Why?
|
Repressor Proteins | 2 | 2018 | 9 | 0.340 |
Why?
|
Gene Expression Profiling | 4 | 2021 | 36 | 0.330 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2007 | 1 | 0.320 |
Why?
|
ErbB Receptors | 1 | 2007 | 13 | 0.320 |
Why?
|
Collagen | 4 | 2022 | 26 | 0.310 |
Why?
|
Protein Kinase Inhibitors | 3 | 2019 | 12 | 0.310 |
Why?
|
Smad Proteins | 2 | 2019 | 10 | 0.300 |
Why?
|
Interleukin-12 | 5 | 2004 | 6 | 0.300 |
Why?
|
Time Factors | 6 | 2015 | 120 | 0.300 |
Why?
|
Multiprotein Complexes | 3 | 2016 | 3 | 0.290 |
Why?
|
NADPH Oxidases | 3 | 2011 | 5 | 0.290 |
Why?
|
Interleukin-1 | 3 | 2004 | 10 | 0.280 |
Why?
|
Magnetic Resonance Imaging | 3 | 2015 | 23 | 0.270 |
Why?
|
Ligation | 9 | 2016 | 10 | 0.270 |
Why?
|
Cell Communication | 2 | 2020 | 5 | 0.270 |
Why?
|
Neoplastic Stem Cells | 2 | 2016 | 25 | 0.260 |
Why?
|
Sirolimus | 2 | 2014 | 4 | 0.260 |
Why?
|
Drosophila Proteins | 2 | 2001 | 9 | 0.260 |
Why?
|
Interleukin-6 | 5 | 2014 | 21 | 0.250 |
Why?
|
Cell Line | 4 | 2022 | 80 | 0.250 |
Why?
|
Caspase 1 | 4 | 2013 | 4 | 0.250 |
Why?
|
Endopeptidases | 3 | 2018 | 9 | 0.240 |
Why?
|
TRPV Cation Channels | 1 | 2023 | 4 | 0.230 |
Why?
|
Middle Aged | 10 | 2021 | 799 | 0.230 |
Why?
|
HSP47 Heat-Shock Proteins | 1 | 2022 | 1 | 0.230 |
Why?
|
Protein Kinase C | 1 | 2022 | 5 | 0.230 |
Why?
|
Cyclins | 1 | 2022 | 7 | 0.230 |
Why?
|
Neovascularization, Pathologic | 3 | 2015 | 21 | 0.230 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2022 | 3 | 0.230 |
Why?
|
Cell Cycle Proteins | 1 | 2022 | 19 | 0.220 |
Why?
|
AMP-Activated Protein Kinases | 2 | 2014 | 31 | 0.220 |
Why?
|
Hepatitis B, Chronic | 1 | 2022 | 1 | 0.220 |
Why?
|
Chemokine CCL3 | 1 | 2022 | 1 | 0.220 |
Why?
|
Chemokine CCL4 | 1 | 2022 | 1 | 0.220 |
Why?
|
Models, Biological | 2 | 2021 | 43 | 0.220 |
Why?
|
Chemokine CCL5 | 2 | 2019 | 3 | 0.220 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2019 | 28 | 0.220 |
Why?
|
Pore Forming Cytotoxic Proteins | 2 | 2020 | 6 | 0.210 |
Why?
|
Genetic Therapy | 3 | 2007 | 18 | 0.210 |
Why?
|
Proto-Oncogene Proteins c-akt | 4 | 2019 | 25 | 0.210 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2021 | 1 | 0.210 |
Why?
|
Amino Acids | 2 | 2021 | 16 | 0.210 |
Why?
|
Mechanotransduction, Cellular | 1 | 2021 | 1 | 0.210 |
Why?
|
Immunity, Innate | 2 | 2011 | 8 | 0.210 |
Why?
|
Cell Movement | 3 | 2010 | 29 | 0.210 |
Why?
|
Adipose Tissue | 1 | 2021 | 42 | 0.200 |
Why?
|
Connexin 43 | 1 | 2021 | 1 | 0.200 |
Why?
|
Indicators and Reagents | 1 | 2021 | 1 | 0.200 |
Why?
|
Choline | 1 | 2021 | 2 | 0.200 |
Why?
|
Pancreatitis-Associated Proteins | 1 | 2020 | 1 | 0.200 |
Why?
|
Bacteroides | 1 | 2020 | 1 | 0.200 |
Why?
|
Polyethylene Glycols | 1 | 2020 | 2 | 0.200 |
Why?
|
Tight Junctions | 1 | 2020 | 2 | 0.200 |
Why?
|
Ligands | 1 | 2020 | 15 | 0.200 |
Why?
|
Administration, Oral | 1 | 2020 | 19 | 0.200 |
Why?
|
Gastrointestinal Microbiome | 1 | 2020 | 6 | 0.200 |
Why?
|
Lactobacillus | 1 | 2020 | 5 | 0.200 |
Why?
|
Forkhead Box Protein M1 | 1 | 2020 | 1 | 0.200 |
Why?
|
Mechanistic Target of Rapamycin Complex 1 | 3 | 2016 | 3 | 0.200 |
Why?
|
Sphingomyelin Phosphodiesterase | 2 | 2010 | 2 | 0.190 |
Why?
|
Proteins | 1 | 2020 | 17 | 0.190 |
Why?
|
Biological Assay | 2 | 2021 | 3 | 0.190 |
Why?
|
Liver Failure | 2 | 2014 | 3 | 0.190 |
Why?
|
Cell Survival | 3 | 2016 | 17 | 0.190 |
Why?
|
Bile Ducts | 6 | 2011 | 6 | 0.190 |
Why?
|
Promoter Regions, Genetic | 3 | 2020 | 25 | 0.190 |
Why?
|
Sequestosome-1 Protein | 2 | 2016 | 3 | 0.180 |
Why?
|
Autophagy-Related Protein 7 | 1 | 2019 | 1 | 0.180 |
Why?
|
Chemokine CXCL10 | 1 | 2019 | 1 | 0.180 |
Why?
|
Biopsy | 5 | 2022 | 16 | 0.180 |
Why?
|
HEK293 Cells | 1 | 2019 | 8 | 0.180 |
Why?
|
Hepacivirus | 3 | 2013 | 4 | 0.180 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 1 | 0.180 |
Why?
|
Dendritic Cells | 3 | 2015 | 23 | 0.180 |
Why?
|
Liver Cirrhosis, Alcoholic | 1 | 2019 | 1 | 0.180 |
Why?
|
Hepatitis, Viral, Human | 1 | 2019 | 2 | 0.180 |
Why?
|
Heat-Shock Proteins | 2 | 2016 | 8 | 0.180 |
Why?
|
Sex Distribution | 1 | 2019 | 22 | 0.170 |
Why?
|
Molecular Chaperones | 1 | 2018 | 4 | 0.170 |
Why?
|
Interleukin-8 | 1 | 2018 | 6 | 0.170 |
Why?
|
GTP-Binding Protein alpha Subunits, G12-G13 | 1 | 2018 | 1 | 0.170 |
Why?
|
Oxygen Consumption | 1 | 2018 | 9 | 0.170 |
Why?
|
Sirtuin 1 | 1 | 2018 | 11 | 0.170 |
Why?
|
Genomics | 1 | 2018 | 4 | 0.170 |
Why?
|
Neoplasm Proteins | 1 | 2018 | 17 | 0.170 |
Why?
|
Oxidation-Reduction | 2 | 2018 | 12 | 0.170 |
Why?
|
NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2018 | 1 | 0.170 |
Why?
|
DNA, Mitochondrial | 1 | 2018 | 10 | 0.170 |
Why?
|
Genes, Tumor Suppressor | 1 | 2018 | 7 | 0.170 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2018 | 11 | 0.170 |
Why?
|
Biomarkers, Tumor | 1 | 2018 | 32 | 0.170 |
Why?
|
Cell Death | 3 | 2016 | 7 | 0.160 |
Why?
|
NF-E2-Related Factor 2 | 2 | 2016 | 3 | 0.160 |
Why?
|
Sensitivity and Specificity | 2 | 2016 | 45 | 0.160 |
Why?
|
Risk Factors | 2 | 2015 | 240 | 0.160 |
Why?
|
Genes, Reporter | 2 | 2014 | 9 | 0.150 |
Why?
|
Hepatic Duct, Common | 1 | 2016 | 1 | 0.150 |
Why?
|
Keratins, Type I | 1 | 2016 | 1 | 0.150 |
Why?
|
Hepatitis, Alcoholic | 1 | 2016 | 3 | 0.150 |
Why?
|
Phenotype | 2 | 2015 | 40 | 0.150 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 3 | 2019 | 7 | 0.150 |
Why?
|
Weight Loss | 2 | 2014 | 17 | 0.150 |
Why?
|
Aged | 5 | 2021 | 607 | 0.150 |
Why?
|
Serum Amyloid A Protein | 1 | 2016 | 1 | 0.140 |
Why?
|
Chemokine CCL2 | 2 | 2016 | 12 | 0.140 |
Why?
|
Twins, Dizygotic | 1 | 2015 | 1 | 0.140 |
Why?
|
Heredity | 1 | 2015 | 1 | 0.140 |
Why?
|
Twins, Monozygotic | 1 | 2015 | 3 | 0.140 |
Why?
|
Receptors, Interleukin-8B | 1 | 2015 | 1 | 0.140 |
Why?
|
Binge Drinking | 1 | 2015 | 2 | 0.140 |
Why?
|
Retinoids | 1 | 2015 | 1 | 0.130 |
Why?
|
Sulfoglycosphingolipids | 1 | 2015 | 1 | 0.130 |
Why?
|
Natural Killer T-Cells | 1 | 2015 | 1 | 0.130 |
Why?
|
Blood Platelets | 1 | 2015 | 2 | 0.130 |
Why?
|
Microbiota | 1 | 2015 | 2 | 0.130 |
Why?
|
Lymphocytes | 1 | 2015 | 13 | 0.130 |
Why?
|
Dactinomycin | 1 | 2014 | 3 | 0.130 |
Why?
|
Green Fluorescent Proteins | 1 | 2014 | 6 | 0.130 |
Why?
|
Overnutrition | 1 | 2014 | 4 | 0.130 |
Why?
|
Vesicular Transport Proteins | 1 | 2014 | 1 | 0.130 |
Why?
|
Microfilament Proteins | 1 | 2014 | 4 | 0.130 |
Why?
|
PPAR alpha | 1 | 2014 | 4 | 0.130 |
Why?
|
Reperfusion Injury | 1 | 2014 | 7 | 0.130 |
Why?
|
Interferon Type I | 1 | 2014 | 1 | 0.130 |
Why?
|
Receptor, Interferon alpha-beta | 1 | 2014 | 1 | 0.130 |
Why?
|
Triglycerides | 2 | 2011 | 36 | 0.130 |
Why?
|
Cytosol | 2 | 2018 | 10 | 0.130 |
Why?
|
Adult | 5 | 2019 | 807 | 0.130 |
Why?
|
Peptidyl-Dipeptidase A | 2 | 2009 | 3 | 0.120 |
Why?
|
Hepatocyte Growth Factor | 2 | 2021 | 2 | 0.120 |
Why?
|
Histone Deacetylase 1 | 1 | 2014 | 1 | 0.120 |
Why?
|
Protein Multimerization | 1 | 2014 | 2 | 0.120 |
Why?
|
Nuclear Receptor Coactivators | 1 | 2014 | 1 | 0.120 |
Why?
|
Haploinsufficiency | 1 | 2014 | 1 | 0.120 |
Why?
|
DNA Repair | 1 | 2014 | 7 | 0.120 |
Why?
|
Glucose Intolerance | 1 | 2014 | 5 | 0.120 |
Why?
|
Cytoskeletal Proteins | 2 | 2023 | 4 | 0.120 |
Why?
|
Calgranulin B | 1 | 2013 | 1 | 0.120 |
Why?
|
Chemokine CXCL2 | 1 | 2013 | 1 | 0.120 |
Why?
|
Chemical and Drug Induced Liver Injury, Chronic | 1 | 2013 | 2 | 0.120 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2013 | 5 | 0.120 |
Why?
|
Molecular Targeted Therapy | 1 | 2014 | 10 | 0.120 |
Why?
|
Autocrine Communication | 1 | 2013 | 1 | 0.120 |
Why?
|
Coculture Techniques | 2 | 2010 | 5 | 0.120 |
Why?
|
Malaria | 2 | 2004 | 2 | 0.120 |
Why?
|
Plasmodium berghei | 2 | 2004 | 2 | 0.120 |
Why?
|
Hepatitis, Animal | 2 | 2004 | 3 | 0.120 |
Why?
|
Enzyme Precursors | 2 | 2004 | 3 | 0.120 |
Why?
|
Interleukin-1alpha | 1 | 2013 | 1 | 0.120 |
Why?
|
DNA Mutational Analysis | 1 | 2013 | 8 | 0.120 |
Why?
|
Caspases | 2 | 2004 | 21 | 0.120 |
Why?
|
Mitogen-Activated Protein Kinase 14 | 1 | 2012 | 3 | 0.120 |
Why?
|
Killer Cells, Natural | 4 | 2011 | 31 | 0.120 |
Why?
|
Rats | 5 | 2016 | 432 | 0.110 |
Why?
|
Tumor Cells, Cultured | 1 | 2013 | 67 | 0.110 |
Why?
|
Primary Graft Dysfunction | 1 | 2012 | 1 | 0.110 |
Why?
|
Acetaminophen | 1 | 2012 | 3 | 0.110 |
Why?
|
Liver Transplantation | 1 | 2012 | 4 | 0.110 |
Why?
|
Chronic Disease | 2 | 2014 | 70 | 0.110 |
Why?
|
Chemokine CXCL12 | 1 | 2012 | 1 | 0.110 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2012 | 7 | 0.110 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2012 | 5 | 0.110 |
Why?
|
Diethylnitrosamine | 3 | 2018 | 4 | 0.110 |
Why?
|
Alanine Transaminase | 2 | 2009 | 10 | 0.110 |
Why?
|
Metabolic Syndrome | 1 | 2012 | 23 | 0.110 |
Why?
|
Bacterial Translocation | 1 | 2011 | 1 | 0.110 |
Why?
|
Metagenome | 1 | 2011 | 2 | 0.110 |
Why?
|
Diet | 1 | 2012 | 40 | 0.110 |
Why?
|
Tryptophan | 1 | 2011 | 5 | 0.100 |
Why?
|
NADH, NADPH Oxidoreductases | 1 | 2011 | 1 | 0.100 |
Why?
|
Central Nervous System Depressants | 1 | 2011 | 8 | 0.100 |
Why?
|
Blotting, Western | 3 | 2022 | 116 | 0.100 |
Why?
|
Nucleic Acid Conformation | 1 | 2010 | 1 | 0.100 |
Why?
|
5' Untranslated Regions | 1 | 2010 | 1 | 0.100 |
Why?
|
RNA Stability | 1 | 2010 | 1 | 0.100 |
Why?
|
DNA | 2 | 2007 | 19 | 0.100 |
Why?
|
Transcription, Genetic | 1 | 2010 | 34 | 0.100 |
Why?
|
CX3C Chemokine Receptor 1 | 1 | 2010 | 2 | 0.100 |
Why?
|
Interleukin-10 | 1 | 2010 | 7 | 0.100 |
Why?
|
Hep G2 Cells | 2 | 2022 | 6 | 0.100 |
Why?
|
Rats, Sprague-Dawley | 4 | 2016 | 179 | 0.100 |
Why?
|
Retrospective Studies | 2 | 2022 | 210 | 0.100 |
Why?
|
Cholestasis, Intrahepatic | 1 | 2010 | 1 | 0.090 |
Why?
|
Cell Division | 1 | 2009 | 39 | 0.090 |
Why?
|
Sex Characteristics | 1 | 2009 | 16 | 0.090 |
Why?
|
Extracellular Matrix Proteins | 1 | 2009 | 6 | 0.090 |
Why?
|
CCR5 Receptor Antagonists | 1 | 2009 | 1 | 0.090 |
Why?
|
Bone Marrow Cells | 1 | 2009 | 2 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinase 8 | 1 | 2009 | 3 | 0.090 |
Why?
|
S-Adenosylmethionine | 2 | 2020 | 13 | 0.090 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2020 | 25 | 0.090 |
Why?
|
Homeodomain Proteins | 1 | 2009 | 9 | 0.090 |
Why?
|
Leptin | 1 | 2008 | 12 | 0.090 |
Why?
|
Primary Cell Culture | 2 | 2020 | 8 | 0.090 |
Why?
|
Angiopoietin-1 | 1 | 2008 | 1 | 0.090 |
Why?
|
RNA Helicases | 1 | 2008 | 1 | 0.080 |
Why?
|
Receptors, Pattern Recognition | 1 | 2008 | 1 | 0.080 |
Why?
|
Hepatitis C, Chronic | 1 | 2008 | 2 | 0.080 |
Why?
|
Acute Disease | 1 | 2008 | 10 | 0.080 |
Why?
|
Suppressor of Cytokine Signaling 1 Protein | 1 | 2007 | 1 | 0.080 |
Why?
|
Suppressor of Cytokine Signaling 3 Protein | 1 | 2007 | 2 | 0.080 |
Why?
|
alpha 1-Antitrypsin Deficiency | 1 | 2007 | 1 | 0.080 |
Why?
|
Neoplasm Regression, Spontaneous | 1 | 2007 | 1 | 0.080 |
Why?
|
Rectal Neoplasms | 1 | 2007 | 1 | 0.080 |
Why?
|
Common Bile Duct | 1 | 2007 | 1 | 0.080 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2007 | 2 | 0.080 |
Why?
|
Colonoscopy | 1 | 2007 | 9 | 0.080 |
Why?
|
Cell Cycle | 1 | 2007 | 14 | 0.080 |
Why?
|
Mice, Inbred C3H | 1 | 2007 | 38 | 0.080 |
Why?
|
Adenocarcinoma | 1 | 2007 | 27 | 0.080 |
Why?
|
Oligonucleotides | 1 | 2007 | 2 | 0.080 |
Why?
|
Prospective Studies | 3 | 2015 | 121 | 0.080 |
Why?
|
Anti-Inflammatory Agents | 1 | 2007 | 11 | 0.080 |
Why?
|
Antigens, CD1 | 2 | 2004 | 3 | 0.080 |
Why?
|
T-Lymphocyte Subsets | 2 | 2004 | 5 | 0.080 |
Why?
|
Collagenases | 1 | 2006 | 3 | 0.070 |
Why?
|
DNA Damage | 2 | 2018 | 16 | 0.070 |
Why?
|
Gastric Bypass | 1 | 2006 | 1 | 0.070 |
Why?
|
Obesity, Morbid | 1 | 2006 | 2 | 0.070 |
Why?
|
Cell Hypoxia | 2 | 2019 | 2 | 0.070 |
Why?
|
Arachidonic Acids | 1 | 2006 | 1 | 0.070 |
Why?
|
Amidohydrolases | 1 | 2006 | 2 | 0.070 |
Why?
|
Cross-Sectional Studies | 3 | 2015 | 267 | 0.070 |
Why?
|
Genes, Immediate-Early | 1 | 2005 | 1 | 0.070 |
Why?
|
Severity of Illness Index | 3 | 2012 | 27 | 0.060 |
Why?
|
Follow-Up Studies | 2 | 2019 | 95 | 0.060 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 1994 | 5 | 0.060 |
Why?
|
Listeriosis | 1 | 2004 | 1 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 2 | 2015 | 7 | 0.060 |
Why?
|
Real-Time Polymerase Chain Reaction | 2 | 2014 | 17 | 0.060 |
Why?
|
Transforming Growth Factor beta1 | 2 | 2018 | 24 | 0.060 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2003 | 2 | 0.060 |
Why?
|
Armadillo Domain Proteins | 1 | 2023 | 1 | 0.060 |
Why?
|
Actins | 3 | 2007 | 17 | 0.060 |
Why?
|
Platelet Count | 1 | 2022 | 1 | 0.060 |
Why?
|
Aspartate Aminotransferases | 1 | 2022 | 2 | 0.060 |
Why?
|
ROC Curve | 1 | 2022 | 12 | 0.060 |
Why?
|
Neoplasms, Experimental | 2 | 2016 | 7 | 0.050 |
Why?
|
NIMA-Interacting Peptidylprolyl Isomerase | 1 | 2022 | 1 | 0.050 |
Why?
|
Casein Kinase II | 1 | 2022 | 1 | 0.050 |
Why?
|
Protein Binding | 1 | 2022 | 17 | 0.050 |
Why?
|
Isoenzymes | 1 | 2022 | 10 | 0.050 |
Why?
|
Weight Gain | 1 | 2022 | 10 | 0.050 |
Why?
|
Adipose Tissue, White | 1 | 2022 | 5 | 0.050 |
Why?
|
Mutation | 1 | 2022 | 28 | 0.050 |
Why?
|
14-3-3 Proteins | 1 | 2021 | 1 | 0.050 |
Why?
|
Polyploidy | 1 | 2021 | 1 | 0.050 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2021 | 1 | 0.050 |
Why?
|
Neoplasm Metastasis | 1 | 2021 | 19 | 0.050 |
Why?
|
Chlamydia Infections | 1 | 2001 | 4 | 0.050 |
Why?
|
Listeria monocytogenes | 1 | 2001 | 1 | 0.050 |
Why?
|
Autophagosomes | 1 | 2021 | 1 | 0.050 |
Why?
|
Autophagy-Related Proteins | 1 | 2021 | 1 | 0.050 |
Why?
|
Coronary Disease | 1 | 2001 | 7 | 0.050 |
Why?
|
Lysosomes | 1 | 2021 | 8 | 0.050 |
Why?
|
Protein Processing, Post-Translational | 1 | 2001 | 15 | 0.050 |
Why?
|
Protein Precursors | 1 | 2001 | 14 | 0.050 |
Why?
|
Fishes | 3 | 2000 | 6 | 0.050 |
Why?
|
Muscles | 3 | 2000 | 17 | 0.050 |
Why?
|
Body Mass Index | 2 | 2014 | 46 | 0.050 |
Why?
|
Feedback, Physiological | 1 | 2020 | 2 | 0.050 |
Why?
|
Hydrocarbons, Fluorinated | 1 | 2020 | 3 | 0.050 |
Why?
|
Thiophenes | 1 | 2020 | 3 | 0.050 |
Why?
|
Datasets as Topic | 1 | 2020 | 4 | 0.050 |
Why?
|
Sulfonamides | 1 | 2020 | 10 | 0.050 |
Why?
|
Dipeptides | 1 | 2000 | 4 | 0.050 |
Why?
|
Antihypertensive Agents | 1 | 2000 | 28 | 0.050 |
Why?
|
Bone Marrow Transplantation | 2 | 2010 | 2 | 0.050 |
Why?
|
Gastrinoma | 1 | 2000 | 1 | 0.050 |
Why?
|
Stomach Neoplasms | 1 | 2000 | 6 | 0.050 |
Why?
|
Hypertension | 1 | 2000 | 56 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 92 | 0.050 |
Why?
|
RNA | 1 | 2019 | 16 | 0.040 |
Why?
|
Benzoxazoles | 1 | 2019 | 1 | 0.040 |
Why?
|
Cell Cycle Checkpoints | 1 | 2019 | 7 | 0.040 |
Why?
|
Adenoviridae | 2 | 2011 | 9 | 0.040 |
Why?
|
Pyrimidines | 1 | 2019 | 6 | 0.040 |
Why?
|
HCT116 Cells | 1 | 2018 | 1 | 0.040 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2018 | 3 | 0.040 |
Why?
|
Energy Metabolism | 1 | 2018 | 12 | 0.040 |
Why?
|
Dietary Fats | 1 | 2018 | 18 | 0.040 |
Why?
|
Smad Proteins, Receptor-Regulated | 1 | 2018 | 1 | 0.040 |
Why?
|
Transcriptome | 1 | 2018 | 18 | 0.040 |
Why?
|
Nucleoside-Phosphate Kinase | 1 | 2018 | 1 | 0.040 |
Why?
|
Biocatalysis | 1 | 2018 | 1 | 0.040 |
Why?
|
Cholic Acids | 1 | 2018 | 1 | 0.040 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2018 | 6 | 0.040 |
Why?
|
Gene Knockdown Techniques | 1 | 2018 | 7 | 0.040 |
Why?
|
Models, Animal | 2 | 2010 | 16 | 0.040 |
Why?
|
Blood Glucose | 2 | 2010 | 110 | 0.040 |
Why?
|
Mice, Nude | 1 | 2018 | 36 | 0.040 |
Why?
|
RNA, Small Interfering | 1 | 2018 | 32 | 0.040 |
Why?
|
Hydrogen Peroxide | 2 | 2007 | 5 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2016 | 3 | 0.040 |
Why?
|
Polymerase Chain Reaction | 2 | 2008 | 35 | 0.040 |
Why?
|
MAP Kinase Kinase 4 | 1 | 2016 | 5 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2016 | 10 | 0.040 |
Why?
|
I-kappa B Kinase | 1 | 2016 | 3 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2016 | 9 | 0.040 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2016 | 2 | 0.040 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2016 | 7 | 0.040 |
Why?
|
Computer Simulation | 1 | 2016 | 16 | 0.040 |
Why?
|
Angiotensin I | 2 | 2009 | 2 | 0.040 |
Why?
|
Angiotensin II | 2 | 2009 | 13 | 0.030 |
Why?
|
Elasticity Imaging Techniques | 1 | 2015 | 1 | 0.030 |
Why?
|
Chi-Square Distribution | 1 | 2015 | 21 | 0.030 |
Why?
|
Transfection | 2 | 2007 | 46 | 0.030 |
Why?
|
Multivariate Analysis | 1 | 2015 | 49 | 0.030 |
Why?
|
California | 1 | 2015 | 93 | 0.030 |
Why?
|
Peptides | 1 | 1994 | 5 | 0.030 |
Why?
|
Necrosis | 2 | 2006 | 3 | 0.030 |
Why?
|
Fats | 1 | 2014 | 1 | 0.030 |
Why?
|
Histocytochemistry | 1 | 2014 | 3 | 0.030 |
Why?
|
Radiography | 1 | 2014 | 9 | 0.030 |
Why?
|
Urokinase-Type Plasminogen Activator | 1 | 2014 | 1 | 0.030 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2014 | 2 | 0.030 |
Why?
|
Lipogenesis | 1 | 2014 | 5 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2014 | 24 | 0.030 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2014 | 1 | 0.030 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2014 | 2 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2014 | 12 | 0.030 |
Why?
|
Regulatory-Associated Protein of mTOR | 1 | 2014 | 1 | 0.030 |
Why?
|
Mitosis | 1 | 2014 | 1 | 0.030 |
Why?
|
Tumor Burden | 1 | 2014 | 15 | 0.030 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2014 | 1 | 0.030 |
Why?
|
Glucose Tolerance Test | 1 | 2014 | 36 | 0.030 |
Why?
|
Mice, Obese | 1 | 2014 | 23 | 0.030 |
Why?
|
Leukocyte L1 Antigen Complex | 1 | 2013 | 1 | 0.030 |
Why?
|
Calgranulin A | 1 | 2013 | 1 | 0.030 |
Why?
|
Wound Healing | 1 | 2013 | 3 | 0.030 |
Why?
|
Hepatitis C | 1 | 2013 | 8 | 0.030 |
Why?
|
Bacillus | 1 | 1993 | 1 | 0.030 |
Why?
|
Oxidative Stress | 1 | 2014 | 102 | 0.030 |
Why?
|
Antigens, CD1d | 2 | 2004 | 2 | 0.030 |
Why?
|
Fas Ligand Protein | 2 | 2003 | 3 | 0.030 |
Why?
|
Hydrolysis | 3 | 2000 | 4 | 0.030 |
Why?
|
Receptors, CXCR4 | 1 | 2012 | 3 | 0.030 |
Why?
|
Ischemia | 1 | 2012 | 3 | 0.030 |
Why?
|
Paracrine Communication | 1 | 2012 | 3 | 0.030 |
Why?
|
Adenosine Triphosphate | 1 | 2012 | 12 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2012 | 32 | 0.030 |
Why?
|
Cohort Studies | 1 | 2012 | 56 | 0.030 |
Why?
|
Cell Differentiation | 1 | 2012 | 79 | 0.030 |
Why?
|
Kynurenine | 1 | 2011 | 2 | 0.030 |
Why?
|
Aromatic-L-Amino-Acid Decarboxylases | 1 | 2011 | 2 | 0.030 |
Why?
|
Fructose | 1 | 2011 | 4 | 0.030 |
Why?
|
Serotonin | 1 | 2011 | 5 | 0.030 |
Why?
|
Lipids | 1 | 2011 | 20 | 0.030 |
Why?
|
Animal Feed | 1 | 2011 | 12 | 0.030 |
Why?
|
NADPH Oxidase 1 | 1 | 2011 | 1 | 0.030 |
Why?
|
NADPH Oxidase 2 | 1 | 2011 | 1 | 0.030 |
Why?
|
Gene Knock-In Techniques | 1 | 2010 | 1 | 0.030 |
Why?
|
Mice, Mutant Strains | 1 | 2010 | 4 | 0.030 |
Why?
|
Glucose Transporter Type 2 | 1 | 2010 | 1 | 0.030 |
Why?
|
Glycogen | 1 | 2010 | 9 | 0.030 |
Why?
|
Protein Biosynthesis | 1 | 2010 | 8 | 0.030 |
Why?
|
Transplantation Chimera | 1 | 2010 | 1 | 0.020 |
Why?
|
Methionine | 1 | 2010 | 2 | 0.020 |
Why?
|
Glucose | 1 | 2010 | 39 | 0.020 |
Why?
|
Lipid Peroxidation | 1 | 2010 | 7 | 0.020 |
Why?
|
Renin-Angiotensin System | 1 | 2009 | 2 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2009 | 13 | 0.020 |
Why?
|
Protein Array Analysis | 1 | 2009 | 1 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2009 | 33 | 0.020 |
Why?
|
Wnt Proteins | 1 | 2009 | 9 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2009 | 13 | 0.020 |
Why?
|
Chimera | 1 | 2009 | 1 | 0.020 |
Why?
|
Hepatitis, Chronic | 1 | 2009 | 1 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 9 | 1 | 2009 | 1 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2009 | 17 | 0.020 |
Why?
|
Cocarcinogenesis | 1 | 2009 | 1 | 0.020 |
Why?
|
Viral Nonstructural Proteins | 1 | 2009 | 2 | 0.020 |
Why?
|
Nanog Homeobox Protein | 1 | 2009 | 2 | 0.020 |
Why?
|
Janus Kinases | 1 | 2008 | 1 | 0.020 |
Why?
|
Receptor, TIE-2 | 1 | 2008 | 1 | 0.020 |
Why?
|
Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2008 | 2 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2008 | 3 | 0.020 |
Why?
|
Gene Expression | 1 | 2008 | 73 | 0.020 |
Why?
|
alpha 1-Antitrypsin | 1 | 2007 | 1 | 0.020 |
Why?
|
Occult Blood | 1 | 2007 | 4 | 0.020 |
Why?
|
Endoplasmic Reticulum | 1 | 2007 | 9 | 0.020 |
Why?
|
Rectum | 1 | 2007 | 6 | 0.020 |
Why?
|
Palliative Care | 1 | 2007 | 6 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2007 | 14 | 0.020 |
Why?
|
Sendai virus | 1 | 2007 | 1 | 0.020 |
Why?
|
Liposomes | 1 | 2007 | 2 | 0.020 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2007 | 4 | 0.020 |
Why?
|
Gene Transfer Techniques | 1 | 2007 | 9 | 0.020 |
Why?
|
Hepatectomy | 1 | 2007 | 1 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2007 | 26 | 0.020 |
Why?
|
Blotting, Northern | 1 | 2007 | 28 | 0.020 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2007 | 5 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2007 | 9 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2007 | 28 | 0.020 |
Why?
|
Desmin | 1 | 2006 | 1 | 0.020 |
Why?
|
Smad2 Protein | 1 | 2006 | 1 | 0.020 |
Why?
|
Smad3 Protein | 1 | 2006 | 1 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2006 | 24 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2007 | 246 | 0.020 |
Why?
|
Muscle, Smooth | 1 | 2006 | 36 | 0.020 |
Why?
|
Matrix Metalloproteinase 13 | 1 | 2006 | 1 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2006 | 10 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2006 | 16 | 0.020 |
Why?
|
Education, Medical, Continuing | 1 | 2006 | 5 | 0.020 |
Why?
|
Liver Function Tests | 1 | 2006 | 4 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2006 | 12 | 0.020 |
Why?
|
Probability | 1 | 2006 | 16 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2006 | 39 | 0.020 |
Why?
|
Prognosis | 1 | 2006 | 47 | 0.020 |
Why?
|
Cholesterol | 1 | 2006 | 21 | 0.020 |
Why?
|
Fatty Acid Transport Proteins | 1 | 2006 | 1 | 0.020 |
Why?
|
Polyunsaturated Alkamides | 1 | 2006 | 1 | 0.020 |
Why?
|
Endocannabinoids | 1 | 2006 | 1 | 0.020 |
Why?
|
Calcium Channel Blockers | 1 | 2006 | 5 | 0.020 |
Why?
|
Glutathione | 1 | 2006 | 13 | 0.020 |
Why?
|
Risk Assessment | 1 | 2006 | 55 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2006 | 133 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2006 | 119 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2006 | 118 | 0.020 |
Why?
|
CARD Signaling Adaptor Proteins | 1 | 2004 | 1 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2004 | 29 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2004 | 1 | 0.020 |
Why?
|
Parasitemia | 1 | 2004 | 1 | 0.020 |
Why?
|
Erythrocytes | 1 | 2004 | 9 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 2004 | 14 | 0.020 |
Why?
|
Injections | 1 | 2004 | 11 | 0.020 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2004 | 18 | 0.020 |
Why?
|
Amino Acid Sequence | 2 | 1994 | 45 | 0.020 |
Why?
|
Th2 Cells | 1 | 2004 | 3 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 1994 | 62 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2004 | 18 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2004 | 18 | 0.020 |
Why?
|
Crohn Disease | 1 | 2003 | 1 | 0.020 |
Why?
|
Viral Core Proteins | 1 | 2003 | 1 | 0.020 |
Why?
|
Fluorescein-5-isothiocyanate | 1 | 2003 | 1 | 0.020 |
Why?
|
Genome | 1 | 2003 | 2 | 0.020 |
Why?
|
Propionibacterium acnes | 1 | 2003 | 2 | 0.020 |
Why?
|
Fluorescent Dyes | 1 | 2003 | 3 | 0.020 |
Why?
|
DNA Primers | 1 | 2003 | 17 | 0.010 |
Why?
|
Transcription Factor RelA | 1 | 2003 | 4 | 0.010 |
Why?
|
Arteriosclerosis | 1 | 2003 | 18 | 0.010 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 2001 | 1 | 0.010 |
Why?
|
Perforin | 1 | 2001 | 5 | 0.010 |
Why?
|
fas Receptor | 1 | 2001 | 3 | 0.010 |
Why?
|
Antibodies, Bacterial | 1 | 2001 | 1 | 0.010 |
Why?
|
Chlamydia | 1 | 2001 | 1 | 0.010 |
Why?
|
Immunoglobulin A | 1 | 2001 | 1 | 0.010 |
Why?
|
Seroepidemiologic Studies | 1 | 2001 | 1 | 0.010 |
Why?
|
Japan | 1 | 2001 | 2 | 0.010 |
Why?
|
Matched-Pair Analysis | 1 | 2001 | 2 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2001 | 5 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2001 | 14 | 0.010 |
Why?
|
Aldosterone | 1 | 2000 | 6 | 0.010 |
Why?
|
Reference Values | 1 | 2000 | 42 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2000 | 48 | 0.010 |
Why?
|
Gastrectomy | 1 | 2000 | 1 | 0.010 |
Why?
|
Gastrins | 1 | 2000 | 1 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2000 | 16 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1994 | 23 | 0.010 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 1993 | 1 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1993 | 14 | 0.010 |
Why?
|